At the end of this informative and interactive symposium, there was an opportunity for the audience to pose questions to the faculty for discussion. Owing to the lack of time, the answers to several questions that were not addressed at the meeting are detailed below. The answers provided reflect the views and opinions of the respondents and are not necessarily those of Eli Lilly and Company. Tadalafil (Cialis) is currently only approved for the treatment of erectile dysfunction (ED).
Audience question: will chronic, long-term administration of tadalafil have beneficial effects on endothelial function?
On the basis of (1) a couple of clinical studies with tadalafil 20 mg every other day (for example, Rosano et al. 1 ), (2) a few pilot clinical studies with sildenafil (for example, Desouza et al.
2 ) and (3) experimental investigations (for example, Behr-Roussel et al.
3 ), one can speculate that the long-term administration of phosphodiesterase type 5 inhibitors and, in particular, tadalafil, because of its long half-life, may exert beneficial effects in patients with endothelial dysfunction of various origins.
Audience question: should all patients with ED be placed on statins?
All men over 40 years of age with organic ED and hyperlipidemia should be placed on statins to achieve a target low-density lipoprotein cholesterol o3.0 mmol/l, and ideally o2.0 mmol/l. They should also be on aspirin 75 mg daily.
Audience question: given the role of calcium in the mechanism of ED, one might theorize that Ca 2 þ channel blockers could be efficacious in ED. Are there any data suggesting their value?
No. Calcium antagonists are fairly neutral regarding ED, with no evidence of benefit in improving ED.
The vasodilating aspect was tried before phosphodiesterase type 5 inhibitors with no success other than when replacing ED-causing drugs such as thiazides.
Audience question: what artery in women has a similar profile (1-2 mm) that might be a predictive indicator of a cardiovascular event for them, assuming normal hormonal status? Is clitoral blood flow a model that merits evaluation? Other?
No studies have been performed. The only easily accessed artery studied is the carotid, which does identify increased risk if abnormal on ultrasound.
Audience question: how do you select a patient to be sent for a coronary angiography? All patients with ED?
Those with cardiac symptoms in spite of conventional medical therapy. Those with a strongly positive exercise electrocardiography for ischemia. Ideally, those at intermediate risk or high risk with no symptoms should undergo computed tomography (CT) angiography. All men with organic ED should be considered for CT coronary angiography, as abnormalities will dictate a more aggressive approach to risk reduction (for example, target low-density lipoprotein cholesterol o2.0 mmol/l).
Audience question: why does ED occur only in two-thirds of patients who have had a stroke?
Stroke has different causes, so there is no unifying pathology/physiology. ED is a common problem after stroke and should be advised on as part of rehabilitation. It is treatable, but specific advice is needed as a couple.
Audience question: if the patient has ED and is treated with tadalafil, can we assume that it will decrease his cardiovascular risk? In other words, can we prevent cardiovascular disease by treating ED?
No, I am not suggesting that treating ED with tadalafil will decrease cardiovascular risk. However, it is an interesting concept as phosphodiesterase type 5 inhibitors have been shown to improve endothelial function. Daily tadalafil in combination with a statin and aspirin may be worth a formal study.
Audience question: what, for the non-cardiologist, is the coronary calcium score and how is it calculated?
Coronary arterial calcification is a common early feature of atherosclerosis. It is measured using electron beam CT or multi-detector CT. The score is derived from the CT number in Hounsfield units and from the number and area of calcium deposits in Agatston units. For a good review, read Erbel et al. Urologists can screen for cardiac risk. Check lipids, glucose, blood pressure and so on. Intermediate and high-risk patients should be referred or sent to their family doctor for comprehensive riskreduction therapy. Low-risk men need lifestyle advice regarding weight, diet and exercise.
Audience question: do you suggest performing a CT angiography for all patients with ED and without cardiovascular disease?
Ideally, all men over 40 years of age with organic ED; men with a positive scan are at an increased risk of cardiovascular disease. Some argue over 30 years of age in high-risk men. An abnormal scan should trigger risk-reduction therapy in those at low apparent risk or where there is doubt.
Audience question: does sex exercise prevent penile arteriosclerosis (like heart exercise prevents heart disease)?
In one study, men over 70 years of age who were sexually active, had a better cardiac prognosis than those who were not. I do not know if regular sexual activity prevents penile endothelial dysfunction-it sounds like a nice idea, and no doubt many would volunteer for a study!
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